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Abstract
Purpose Research has demonstrated cognitive benefits following acute polyphenol-rich berry consumption in children and 
young adults. Berry intake also has been associated with metabolic benefits. No study has yet examined cognitive perfor-
mance in middle-aged adults. We investigated the relationships among cognitive and metabolic outcomes in middle-aged 
adults following wild blueberry (WBB) consumption.
Methods Thirty-five individuals aged 40–65 years participated in a randomized, double blind, cross-over study. Participants 
consumed a breakfast meal and 1-cup equivalent WBB drink or matched placebo beverage on two occasions. Participants 
completed cognitive tasks and had blood drawn before and at regular intervals for 8 h after each meal/treatment. Changes in 
episodic memory and executive function (EF) were assessed alongside plasma levels of glucose, insulin, and triglyceride.
Results Analysis of the memory-related Auditory Verbal Learning Task (AVLT) word recognition measure revealed a 
decrease in performance over the test day after placebo intake, whereas performance after WBB was maintained. For the 
AVLT word rejection measure, participants identified more foils following WBB in comparison to placebo. Benefits were 
also observed for EF on the Go/No-Go task with fewer errors following WBB intake on cognitively demanding invalid 
No-Go trials in comparison to placebo. Furthermore, in comparison to placebo, response times were faster for the Go/No-Go 
task, specifically at 4 h and 8 h following WBB treatment. We also observed reduced post-meal glucose and insulin, but not 
triglyceride, concentrations in comparison to placebo over the first 2 h following ingestion. Though the addition of Age, 
BMI, glucose and insulin as covariates to the analysis reduced the significant effect of beverage for AVLT word rejection, 
metabolic outcomes did not interact with treatment to predict cognitive performance with the exception of one isolated trend.
Conclusions This study indicated acute cognitive benefits of WBB intake in cognitively healthy middle-aged individuals, 
particularly in the context of demanding tasks and cognitive fatigue. WBB improved glucose and insulin responses to a meal. 
Further research is required to elucidate the underlying mechanism by which WBB improves cognitive function.
Keywords Wild blueberry · Cognition · Executive function · Glucose · Insulin · Fruit · Polyphenols
Introduction
There is a substantial body of evidence demonstrating an 
association between habitual consumption of foods high 
in flavonoids and cognitive benefits [1] including delayed 
cognitive decline with ageing [2, 3]. In addition, evidence 
from controlled intervention trials corroborate these find-
ings, showing that supplementation with flavonoid-rich 
foods produce improvements in cognitive performance (for 
reviews see [4, 5]).
The majority of human berry trials have investigated 
the effects of supplementation for periods of several weeks 
[6–12], although recent data suggest that effects of other 
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flavonoid-rich food, such as cocoa, on brain function [13, 14] 
and neurocognitive function [15, 16] can occur within hours 
of consumption. Likewise, in school-aged children, whole 
fruit blueberry powder delivered in a smoothie/juice drink 
was associated with improvements in executive function 
and memory performance 2–6 h following intake [17–20]. 
In young adults, a smoothie of equal blueberry, strawberry, 
raspberry, and blackberry, was associated with improve-
ments in executive function, again 2–6 h following intake 
[21]. Furthermore, in older adults, global cognitive function 
was found to decline relative to baseline at 2 h following a 
control beverage whereas performance was maintained for 
a flavonoid-rich blueberry beverage [22]. Importantly, these 
improvements in cognitive performance were demonstrated 
following berry intake at intervals similar to plasma peaks 
of blueberry anthocyanins and their metabolites 1–3 h after 
ingestion, as well as plasma peaks of different phenolic acid 
metabolites 2–3 h and 5 h post-consumption [23–25].
Related to these timescales, reduced postprandial insu-
lin (1–3 h) and attenuated postprandial inflammation have 
been shown to occur for up to 10 h in middle-aged, over-
weight and obese individuals consuming strawberries with 
a typical Western meal, and in a younger overweight group 
consuming strawberries 2 h before the meal, respectively 
[26, 27]. Similarly, red raspberry intake with a high carbo-
hydrate breakfast meal reduced postprandial glycaemia and 
the concomitant insulin demand in overweight or obese indi-
viduals with pre-diabetes and insulin resistance [28] across 
time frames that anthocyanin and phenolic metabolites were 
apparent in blood [29]. Further, in a dose response study in 
individuals with obesity and insulin resistance, insulin and 
glucose responses after strawberry intake with a meal were 
associated with the main anthocyanin metabolite of straw-
berry, pelargonidin glucuronide [30].
Collectively, there is evidence suggesting that cognitive 
benefits after a single administration of polyphenol-contain-
ing berry fruits occurs during a timeframe corresponding to 
both the pharmacokinetic profiles of berry (poly)phenols 
and biological effects associated with metabolic health. 
Notably, observational data suggest a strong link between 
metabolic syndrome and cognitive impairment [31], sug-
gesting that dietary components and/or their metabolites 
that impact metabolic systems, also might impact cognitive 
function. However, these factors and their relationships have 
not been investigated in a clinical trial. Also, while evidence 
of immediate cognitive benefit following polyphenol intake 
has been observed in school-aged children, young adults, 
and older adults, there is limited research to date concern-
ing such cognitive effects in middle-age, a period that is 
noteworthy because of the association of mid-life health 
conditions, particularly metabolic disturbance, with risk for 
late-life dementia [32]. Therefore, the aim of this study was 
to examine relationships among cognitive performance and 
metabolic responses in middle-age adults following one-time 
intake of whole fruit wild blueberry powder.
Method
The study was registered with identifier NCT02736331 on 
ClinicalTrials.gov, and participants reviewed and signed an 
informed consent document approved by the Institutional 
Review Board, Illinois Institute of Technology, Chicago, IL, 
USA. The study was performed in accordance with the ethi-
cal standards laid down in the 1964 Declaration of Helsinki 
and its later amendments. Study participants were recruited 
from the Greater Chicagoland area, and study visits were 
conducted at the Clinical Nutrition Research Centre (CNRC) 
at Illinois Institute of Technology, Chicago, IL, USA.
Participants
We advertised for participants who were middle aged and 
who were between 40 and 65 years old with BMI between 
18.5 and 34.9 kg/m2. Participants were required to be non-
smokers for at least two years, able to understand the require-
ments of the cognitive function tasks, not taking medications 
that might interfere with study outcomes such as glycaemic, 
lipid-lowering, and psychostimulant medications, and with-
out cardiovascular, respiratory, renal, gastrointestinal, and 
neurological disorders.
Sixty-five individuals were screened for the study and 25 
were disqualified for the following reasons, ineligible BMI 
(n = 1), medical concerns (n = 7), failure to adequately per-
form cognitive tasks (n = 1), recent/current smoker (n = 3), 
lifestyle patterns that would influence study objectives 
(n = 3), loss to follow up (n = 3), and withdrawal of con-
sent (n = 7). Of the 40 participants who were randomized, 
3 participants were withdrawn due to medical concerns and 
another 2 due to poor adherence to study procedures.
Study design and experimental beverages
The study was a randomized investigator- and subject-
blinded, 2-arm, placebo-controlled, cross-over trial. Par-
ticipants received one of the experimental beverages with 
a breakfast meal on two occasions separated by at least 
7 days determined by a computer generated randomization 
sequence. The study visits required 9–9.5 h subjects’ time 
and followed an identical protocol with the exception of the 
administered drink: wild blueberry or placebo beverages.
The wild blueberry beverage consisted of 25 g freeze-
dried whole wild blueberry (WBB) powder (~ 1-cup fresh 
weight) sourced from the Wild Blueberry Association of 
North America, Old Town, Maine, USA and freeze-dried, 
analysed and packaged by FutureCeuticals, Momence, IL. 
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The WBB powder was mixed with water, frozen lemonade 
concentrate, and unsweetened Kool-aid for colour and fla-
vouring. The placebo beverage was matched as closely as 
possible for energy and macronutrient content using the 
same ingredients minus the WBB powder. The breakfast 
meal included buttermilk biscuits with unsalted butter and 
apple jelly, scrambled eggs, and honeydew melon balls. 
The breakfast meal and beverages were consumed together. 
Table 1 contains the nutritional composition of the bever-
ages and Table 2 provides the nutritional composition of the 
breakfast meal. 
Study procedures
After screening and enrolment, all participants underwent a 
pre-study visit to obtain 3-day dietary records and become 
familiar with study day cognitive tasks. Dietary records were 
collected to counsel participants on convenient ways to com-
ply with avoiding berry products and high polyphenol/antho-
cyanin foods during the study. To minimize practice effects 
participants were administered two full practice versions 
with the cognitive tasks during the pre-study visit.
After the pre-study visit, participants were scheduled for 
the first study visit. Study procedures required participants 
to maintain usual dietary and activity habits throughout the 
experimental period, except that berry products were to be 
avoided for at least seven days prior to each study visit. Prep-
aration the day before each study required participants to 
consume 8–10 cups of water and avoid alcohol 24-h before 
each study day. The evening meal before a study day visit 
was controlled by limiting participants’ choice to purchasing 
a meal from a local sandwich shop or taking a standardized 
meal from the CNRC. Participants ate the same meal before 
each study visit. Participants were instructed to begin a water 
only fasting protocol after 10:00 pm.
Upon arrival at the CNRC for each study day visit, par-
ticipants were asked to confirm the period of their fast (time 
documented since last food or drink), and compliance with 
avoidance of berry and polyphenol/anthocyanin rich foods. 
Height, body weight, waist circumference, and body tem-
perature were measured. Fasting blood glucose levels were 
obtained via finger prick, and blood pressure and heart rate 
were measured three times at five minutes intervals. An 
intravenous catheter was placed in the non-dominant arm 
and participants completed the baseline set of cognitive 
tasks while fasted. Following completion of the baseline 
assessment, a blood sample was collected and participants 
were provided the standardized breakfast including either the 
wild blueberry or placebo beverage based on a randomized 
sequence. As shown in Fig. 1, blood samples were collected 
Table 1  Nutritional composition of treatment  beveragesa
a Beverages were served with the standardized breakfast. Data are 
derived from ESHA software, Salem, Oregon, USA methods section
b WBB Beverage (348 g): freeze-dried WBB powder, lemonade fro-
zen fruit concentrate (Minute Maid, Sugarland, TX), Black Cherry 
Kool-aid drink mix (Kraft, Northfield IL), Grape Kool-aid drink mix 
(Kraft, Northfield, IL) and water
c Control Beverage (348 g): lemonade frozen fruit concentrate (Min-
ute Maid, Sugarland, TX), Black Cherry Kool-aid drink mix (Kraft, 
Northfield IL), Grape Kool-aid drink mix (Kraft, Northfield, IL) and 
water
d Values are provided by Reading Scientific Services LTD, Reading 
UK
e Values are calculated from certificate of analysis provided by Future-
ceuticals, Momence, Indiana: total polyphenols present in powder at 
2.9% by FCCM C.2.4 method and total anthocyanins present in pow-
der at 1.9% by FCCM C.13.1 method
Nutrient WBB  beverageb Control 
 beveragec
Energy (kcal) 153 152
Carb (g) 33 34
Protein (g) 1 0
Fat (g) 1 0
Fibre (g) 4 0







Polyphenols (mg)e 725 0
Anthocyanins (mg)e 475 0
Energy density (kcal/g) 0.4 0.4
Table 2  Nutritional composition of standardized  mealsa
a Standardized breakfast was served with treatment beverages. All 
meals analysed by ESHA software 2018, Version 11.6.522, Salem, 
Oregon, USAand PhenolExplorer for polyphenols content
b Breakfast meal included buttermilk biscuits (Pillsbury General 
Mills, Minneapolis, MN), unsalted butter (Ahold USA INC, Lando-
ver, MD), apple jelly (Smuckers, Orrville, OH), scrambled eggs 
(Dutch Farms, Chicago, IL), and fresh honeydew melon balls
c Light Lunch was served after the 6 h blood collection and cognitive 
assessment. Lunch included freshly sliced cucumbers without skin, 
Cucumber Ranch salad dressing (Kraft, Northfield, IL), fresh parsley, 






Energy (kcal) 690 249
Carb (g) 88 11
Protein (g) 14 8
Fat (g) 33 20
Fibre (g) 1 3
Sugar (g) 44 5
Polyphenols (mg)  < 1  < 1
Anthocyanins (mg) 0 0
Energy density (kcal/g) 1.8 1.0
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at 30, 60, 120, 180, 240, 300, 360, and 480 min after the start 
of the meal, and matched versions of the cognitive tasks 
were repeated at 120, 240, 360, and 480 min after the meal 
and immediately after blood collection. A lunch consisting 
of cucumber salad with peanuts was provided at 420 min. 
All study foods were prepared in the Metabolic Kitchen of 
CNRC following food safety standards as dictated in the 
CNRC Standard Operating Procedures. After the 480-min 
assessments, the catheter was removed and participants were 
evaluated for safety before discharge.
Study assessments
Cognitive evaluation
E-prime V2 (Psychology Software Tools, Inc) was used to 
display stimuli and record participants’ responses. Auditory 
stimuli were presented through noise cancelling enclosed 
headphones. The cognitive protocol was designed to evalu-
ate executive control functions essential to working memory 
and new learning and retention (long-term memory). These 
domains are characteristically vulnerable to decline with 
aging beginning in midlife [33]. The protocol included two 
tasks measuring executive abilities and one test of episodic 
memory.
A computer-administered version of the Auditory Ver-
bal Learning Task (AVLT) examined learning, recall and 
recognition memory [18, 34]. Such a word list learning 
task generally makes lower demand on executive ability 
than other types of learning and memory tasks such as 
complex figure and paragraph recall, tasks that involve 
integration and organization of complex material [35]. 
Participants were presented with five auditory exposure 
and immediate oral recall trials of a pre-recorded list of 
15 common words (list A, trials 1–5) followed by one 
exposure and free recall trial of an interference list of 15 
words (list B). After the recall for list B and without fur-
ther exposure to list A, another recall trial (list A, trial 6) 
for list A was elicited. Following a 15 min delay inter-
val, during which participants engaged in other cognitive 
tasks, participants were asked to recall the items from list 
A again. Immediately following this recall trial, partici-
pants performed a word recognition task where they were 
exposed to a list of 50 words displayed one at a time on the 
screen containing the words from lists A and B along with 
20 foils. They were asked to respond by pressing a green 
‘Y’ key when shown words from list A and a red ‘N’ key 
when shown words from list B or the 20 other foils. Ten 
balanced word lists were used in this study (as previously 
reported [18]) with list presentation randomized using a 
balanced Latin square across the 10 cognitive test sessions.
Measures drawn from the AVLT included: (1) immedi-
ate recall following list A trial 1; (2) total number of words 
learned (a measure of the number of additional words 
learned between list A trial 1 and list A trial 5, calculated 
as recall in trial 5 minus recall in trial 1); (3) final acquisi-
tion (a measure of the total number of words learned fol-
lowing all 5 presentations of list A, calculated as recall in 
trial 5); (4) proactive interference (a measure of the effect 
of previously encoded information on the acquisition of new 
information calculated as the number of words recalled from 
list B minus number of words recalled in list A trial 1); (5) 
retroactive interference (a measure of the effect of newly 
encoded information on the recall of previously encoded 
information, calculated as the number of words recalled in 
list A trial 5 minus number of words recalled in list A trial 
6 – note the newly encoded information in this case is the 
presentation and recall of list B which separates list A, trials 
5 and 6); (6) delayed recall (number of list A words recalled 
after the 15 min delay); (7) word recognition accuracy and 
reaction time (number of true positives out of the possible 15 
list A items); (8) word rejection accuracy and reaction time 
Fig. 1  Time line of procedure, blood draws and cognitive testing on test days
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(number of true negatives out of the possible 35, consisting 
of the 15 list B items and 20 foils).
The Modified Attention Network Task (MANT) assessed 
susceptibility to response interference by having participants 
respond on a keyboard indicating the direction of a stimulus 
arrow displayed on a computer screen either directly above 
or below a central fixation cross [19]. Alerting (either a star 
replacing the fixation cross, or no cue) and orienting (either 
one star displayed directly above or below the fixation in the 
position of the next stimulus arrow, or two stars displayed 
simultaneously directly above and below the fixation cross) 
cues were presented 120 ms before each stimulus presenta-
tion, followed by a 450 ms fixation screen. The stimulus was 
then presented for 500 ms. Congruence was manipulated by 
the direction of the central arrow which could either be con-
gruent (same direction) or incongruent (opposite direction) 
to the surrounding arrows. Visual load was manipulated by 
the number of flanking arrows which could either be 10, 
5 or none. An inter-stimulus interval fixation screen was 
then displayed for 1000 ms before the next cue. Measures 
of accuracy and reaction time were gathered by congruency 
and load.
Finally, the Cued Go/No-Go task [36] examined response 
inhibition by having participants respond to empty cue rec-
tangles. Following a variable duration of 100, 200, 300, 400 
or 500 ms, the cue rectangles were then filled with green 
“go” or blue “no-go” stimuli. Vertical rectangles were fol-
lowed on 80% of trials by the blue “no-go” stimuli (valid 
“no-go” cues), while the remaining 20% of vertical rectan-
gles were followed by green “go” stimuli (invalid “go” cues). 
Horizontal rectangles were followed on 80% of trials by a 
green ‘go” stimuli (valid “go” cues), the remaining 20% of 
horizontal rectangles were followed by blue “no-go” stimuli 
(invalid “no-go” cues). Thus, the orientation of the rectangle 
cued the participant to the predominant stimulus type that 
followed. Where a vertical “no-go” cue rectangle is followed 
by a go stimulus slower reaction times were expected due to 
the additional cognitive demand placed on the participant 
to overcome the pre-potent prime to withhold a response. 
Conversely where a horizontal “go” cue is followed by a 
“no-go” stimulus, increased errors of commission were 
expected due to the additional cognitive demand placed on 
the participant to overcome the pre-potent prime to make a 
“go” response. Reaction time by cue type was measured for 
“go” stimuli and number of commission errors by cue type 
was measured for “no-go” stimuli.
Metabolic and lipid assays
Blood samples were collected in vacutainer tubes coated 
with ethylenediaminetetraacetic acid (EDTA). Samples were 
centrifuged at 453 × g for 15 min at 4  °C. Plasma was col-
lected and stored at  – 80 °C until analysed. Glucose, insulin, 
and triglyceride levels were measured using enzymatic calo-
rimetric methods (Randox, UK – Cat # 3815), immunotur-
bidimetry assay methods (Kamiya Biomedicals, WA, USA 
– Cat # KAI-071) and standardized enzyme-based assay 
methods (Randox, UK – Cat # TR3823), respectively. All 
assays were performed on the Randox Daytona automated 
clinical analyser (Randox, UK) according to manufacturer’s 
instructions. Quality controls were applied throughout sam-
ple analysis.
Statistical analysis
The participant sample characteristics were tabulated using 
descriptive statistics. Statistical analyses of the cognitive 
measures were performed using SPSS v25 linear mixed 
modelling (LMM) employing an unstructured covariance 
matrix to model successive repeat measurements. ‘Partici-
pant’ was included as a random factor to control for non-
independence of data within participants. In our primary 
analysis of the cognitive data, for all cognitive tasks, Visit 
Order (Visit), Time after experimental beverage (Time), 
experimental beverage (Beverage), and Time × Beverage 
interaction were included as fixed factors in the model. For 
the Cued Go/No-Go, the following additional fixed factors 
were included; Cue type, Beverage × Cue type, and Bev-
erage × Cue Type × Time. For the MANT the following 
additional fixed factors were included; Congruency, Load, 
Beverage × Congruency, Beverage × Load, Beverage × 
Congruency × Load, Beverage × Congruency × Time, Bev-
erage × Load × Time, and Beverage × Congruency × Load 
× Time.
Metabolic and lipid data were tested for normality using 
Shapiro–Wilk tests and log transformed when indicated 
(i.e. insulin, triglyceride). Glucose, insulin and triglyceride 
measures were analysed by repeated measures analysis of 
variance (ANOVA) in a mixed model procedure using SAS 
v9.4. The primary analysis was similar to that performed 
on cognitive data using Time, Beverage, and Time x Bever-
age interaction, and Visit, Beverage, and Visit x Beverage 
interaction as fixed variables and participants as the random 
factor. Area under the curve analysis (AUC) was performed 
using total area under the response curve for 480 min as well 
as in increments of 120 min.
To understand the relationship of metabolic and lipid fac-
tors with cognitive outcomes, a secondary LMM analysis 
included the fixed factors as described above with Insulin, 
Glucose, BMI, and Age as covariates along with the interac-
tion between each of these covariates and Beverage. AUC 
for the first 120 min for Insulin and Glucose was utilized in 
these models based on the hypothesized impact of the initial 
post-meal metabolic response on downstream cellular and 
systemic alterations (increased oxidative stress and inflam-
matory responses) [26, 27].
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To estimate statistical power in this preliminary study, 
we assumed a medium effect size and alpha probabil-
ity = 0.05. Given the sample size estimate of 35 partici-
pants, power = 0.69. Trends in statistical significance were 
acknowledged with alpha probability 0.05–0.1. In all analy-
ses, multiple pairwise comparisons with Bonferroni cor-
rection for familywise error were applied. This included 
non-significant interactions; which is statistically appro-




Forty individuals were enrolled of which 35 completed the 
pre-study visit and both study days. The 35 completers had a 
mean (± SD) age of 50.9 ± 7.8 and BMI of 26.7 ± 4.1 kg/m2. 
Table 3 contains a summary of participant characteristics.
Cognitive function
Auditory verbal learning test
Significant effects on the AVLT were found only for the 
recognition memory component of the task where partici-
pants were asked to identify from a list of 50 words those 
that had been presented in the initial word list (from trial 
1), the interference word list (list B), and 20 novel foils. As 
would be expected in relation to cumulative interference 
effects, both Visit [F(1, 34.5) = 8.74, p = 0.006], with par-
ticipants performing less accurately at Visit 2 (M = 0.716) 
in comparison to Visit 1 (M = 0.769), and Time [F(1, 
70) = 3.84, p = 0.007], with participants performing less 
well over the course of the day, predicted accuracy of 
word recognition. Beverage [F(1, 36.3) = 0.002, p = 0.97] 
and the Beverage x Time interaction [F(4, 70) = 1.084, 
p = 0.371] failed to reach significance. However, as shown 
in Fig. 2a, pairwise comparisons revealed a significant 
reduction in accuracy for the placebo condition between 
baseline and 120 min [p = 0.015], 360 min [p = 0.02] and 
480 min [p = 0.043]. No such reduction in accuracy was 
found for the WBB condition where recognition perfor-
mance was not different at any post-ingestion assessment 
point.
For performance based on accuracy of word rejec-
tion, Visit and Time significantly predicted performance 
[F(1, 35.4) = 4.56, p = 0.04; F(4,70) = 4.96, p = 0.001, 
respectively] with participants performing more accu-
rately at Visit 2 (M = 0.822) in comparison to Visit 1 
(M = 0.804), and with participants performing worse (i.e., 
less accurately) over the course of the day as shown in 
Fig. 2b. In addition, there was an effect of Beverage [F(1, 
39.5) = 6.65, p = 0.014] with WBB-treated participants 
accurately identifying more foil words (M = 0.825) than 
those under placebo conditions (M = 0.80). The Bever-
age x Time interaction trended towards significance [F(4, 
70) = 2.01, p = 0.094], and pairwise comparisons indi-
cated relatively better performance following WBB in 
comparison to placebo, particularly evident at 240 min 
[p = 0.002]. Significant decreases in accuracy were also 
found for WBB-treated participants between baseline and 
360 min [p = 0.02] and 240 min and 360 min [p = 0.045], 
and significant decreases in accuracy for placebo partici-
pants between baseline and 240 min [p = 0.04] and base-
line and 480 min [p = 0.033].
There was no effect of the Beverage on measures of learn-
ing, proactive interference (PI), retroactive interference (RI), 
and recognition memory reaction time (RT). Similarly, there 
was no main effect of Beverage or Beverage × Time interac-
tion on delayed recall, however, pairwise placebo compari-
sons did show diminished recall associated with both WBB 
and placebo treatments with the exception of a short-lived 
improvement following placebo between 120 and 240 min 
[p = 0.047].
Modified attention network task
As expected, Congruency [F(1, 243.7 = 98.4, p < 0.001] and 
Load [F(1, 243.7) = 8.22, p = 0.004] influenced response 
accuracy. There was no main effect of Beverage on response 
accuracy. There was a Beverage × Congruency × Load inter-
action [F(2, 243.68) = 3.16, p = 0.044], however, although 
pairwise comparisons revealed only one significant finding 
whereby there was a short-lived reduction in accuracy on 
incongruent, high load trials between 240 and 360 min for 
Table 3  Demographic information of participants




Body Mass Index (kg/m2)              27 ± 4
Fasng Capillary Glucose (mg/dL)              93 ± 9
Systolic Blood Pressure (mmHg)            112 ± 11
Diastolic Blood Pressure (mmHg)              72 ± 9
N
Male                  12    Gender (n)
Female                  23    
Caucasian                    9    
African American                  18    
Asian                     4     
Race/Ethnicity (n)
Hispanic                     4   
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the placebo treatment, there were no significant between 
treatment pairwise comparisons for this measure (see Fig. 3).
For the RT analysis, the expected Congruency 
[F(1,212.5) = 896.3, p < 0.001] and Load [F(1,212,5) = 76.8, 
p < 0.001] effects were observed, however, no significant 
treatment-related RT effects were found for this task. For 
both beverages, pairwise comparisons revealed significant 
improvements in RT between all-time points with the excep-
tion of baseline and 120 min, and 120 min and 240 min 
for WBB treatment, and baseline and 120 min, 120 and 
240 min, 120 and 360 min, and 240 and 360 min for the 
placebo treatment. There were no significant between treat-
ment pairwise comparisons for this measure (see Fig. 4).
Go/No‑Go task
Cue type [F(1,104) = 11.98, p = 0.001] predicted errors, 
with ‘Go cues’ leading to more errors (M = 0.028) in com-
parison to No-Go cues’ (M = 0.011). A trend towards sig-
nificance was found for Visit [F(1, 110) = 3.42, p = 0.067], 
Fig. 2  a Mean word recogni-
tion accuracy (± Standard error 
of the mean) at all-time points 
following WBB or control inter-
vention. Placebo accuracy can 
be seen to significantly decrease 
between baseline and 120 min, 
360 min, and 480 min whereas 
no such decrease is found for 
WBB. b Mean word rejection 
accuracy (± Standard error of 
the mean) at all-time points 
following WBB or control 
intervention. Placebo accuracy 
can be seen to significantly 
decrease between baseline 
and 240 min, and baseline and 
480 min. WBB accuracy can be 
seen to significantly decrease 
between baseline and 360 min 
and 240 min and 360 min
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with participants making more errors at Visit 2 (M = 0.024) 
in comparison to Visit 1 (M = 0.016), and for Time [F(4, 
139) = 2.42, p = 0.051], with participants performing less 
accurately later in the day. There was no effect of Beverage 
[F(1, 104.4) = 2.47, p = 0.119], Beverage x Time interac-
tion [F(4, 67) = 1.084, p = 0.371], or Beverage x Cue x 
Time interaction [F(8, 139) = 0.825, p = 0.582]. There was 
a trend towards significance for the Beverage x Cue inter-
action [F(1,104) = 3.36, p = 0.07]. Pairwise comparisons 
(via post hoc Bonferroni) revealed no beverage-related 
effect for the valid, less cognitively demanding, No-Go 
cues (see Fig. 5a). Pairwise comparisons did, however, 
reveal a difference between WBB (M = 0.02) and placebo 
(M = 0.037) for the more cognitively demanding invalid 
Go cues [p = 0.018]. Figure 5b shows the increase in errors 
for placebo between baseline and 480 min [p = 0.013] 
and between 360 and 480 min [p = 0.042] for invalid Go 
cues, whereas errors were maintained at the same level 
across the assessment points following WBB treatment. 
Indeed, WBB was associated with better performance at 
120 min (WBB M = 0.016 vs placebo = 0. 037; [p = 0.03]) 
and at 480 min (WBB M = 0.023 vs placebo M = 0.05; 
[p = 0.019]).
Cue type also predicted RT on the Go/No-Go task 
[F(1,101) = 13.7, p < 0.001]. There was no main effect 
of Beverage [F(1,100.6) = 1.88, p = 0.173] but the Bev-
erage x Time interaction trended towards significance 
[F(4,140) = 3.36, p = 0.050] and, as shown in Fig. 6, for ‘go’ 
trials regardless of cue type, pairwise comparisons showed 
faster performance following WBB in comparison to pla-
cebo at 240 min (M = 330 ms vs M = 337 ms; [p = 0.036]) 
and 480 min (M = 329 ms vs M = 337 ms; [p = 0.034]). 
Fig. 3  Mean accuracy perfor-
mance (± Standard error of 
the mean) at all-time points 
following WBB or control 
intervention
Fig. 4  Mean reaction time 
(± Standard error of the mean) 
at all-time points following 
WBB or control interven-
tion. Note, as described in 
the text, for both beverages, 
pairwise comparisons revealed 
significant improvements in 
RT between a number of time 
points
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Furthermore, at 480 min, Go trial RTs were significantly 
faster following WBB treatment when primed with a 
cognitively demanding No-Go cue (M = 235 vs M = 345; 
[p = 0.049]).
Postprandial glucose, insulin and triglyceride 
responses
Postprandial glucose, insulin, and triglycerides increased 
after both Beverages [Time effect: glucose F(558) = 66.7, 
p < 0.001, insulin F(551) = 328.2, p < 0.001, triglyceride 
F(554) = 42.1, p < 0.001]. Peak glucose and insulin concen-
trations occurred at 30 min and 60 min after placebo and 
WBB, respectively (Figs. 7 and 8). Postprandial triglycer-
ide concentrations peaked at 240 min after both treatments 
(Fig. 9). Mean postprandial glucose, insulin and triglycer-
ide concentrations over 480 min was not different between 
treatments [p > 0.05 for all]. As shown in Fig. 10, AUC 
analysis of the post-meal increments of 120 min indicated a 
significant reduction in glucose and insulin concentrations 
after WBB vs placebo beverages within the first 120 min 
after breakfast [AUC 0-120, p = 0.03 and p = 0.01] but were 
Fig. 5  a Mean number of errors 
for congruent No-Go Cues 
(± Standard error of the mean) 
at all-time points following 
WBB or control intervention. 
b Mean number of errors for 
incongruent Go Cues (± Stand-
ard error of the mean) at all-
time points following WBB or 
placebo intervention [significant 
difference between treatments, 
p = 0.018]. In comparison to 
WBB, there were significantly 
more errors for the placebo con-
dition at 120 min and 480 min. 
Placebo condition errors can be 
seen to increase significantly 
between baseline and 480 min 
and between 360 and 480 min, 
whereas the number of errors 
remain constant for WBB
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not different between treatments thereafter [AUC 120-240 and 
AUC 240-360 and AUC 360-240 p > 0.05].   
Metabolic, age, and BMI covariate analysis
AVLT
Including the covariates Age, BMI, and AUC 0-120 of Glu-
cose and Insulin in the models did not influence the pattern 
of significance for the episodic memory measures with the 
exception of Word Rejection accuracy where the main effect 
of Beverage was no longer significant [F(1,34.7) = 1.39, 
p = 0.246]. The Beverage x Time interaction trend towards 
significance remained [F(4,70) = 2.08, p = 0.093] as did the 
significant pairwise comparisons for this measure, which, in 
particular, suggested improved WBB performance in com-
parison to placebo at 240 min [p = 0.002].
The covariate, BMI, predicted performance or inter-
acted with Beverage on the following measures: Imme-
diate Recall, trend [F(1,38.4) = 3.89, p = 0.056]; Total 
Number of Words Learned, BMI × Beverage trend inter-
action [F(1,34.3) = 3.90, p = 0.056] for both WBB and 
placebo, as BMI increased, performance decreased [WBB 
beta =  – 0.139, placebo beta =  – 0.032]; Final Acquisition, 
Fig. 6  Mean RT for all Go/
No-Go ‘go’ trials regardless of 
cue type (± Standard error of 
the mean) at each time point 
following WBB or placebo 
intervention. There was a 
marginally significant treatment 
x time interaction with WBB 
performing faster than placebo 
at 240 min and 480 min. 
Note: For the second analysis 
including Age, BMI, AUC 0-120 
glucose and AUC 0-120 insulin 
as covariates, the main effect 
of treatment was marginally 
significant (p = 0.053)
Fig. 7  Glucose response over 
the 480 min following WBB 
and placebo treatment
European Journal of Nutrition 
1 3
trend [F(1,37.5) = 3.65, p = 0.064], there was also a BMI 
x Beverage interaction for this measure [F(1,33.4) = 4.153, 
p < 0.05] for both WBB and placebo, as BMI increased, 
performance decreased [WBB beta =  – 0.226, pla-
cebo beta =  – 0.147]; Delayed Recall [F(1,36.2) = 6.61, 
p = 0.014], there was also a BMI × Beverage interaction for 
this measure [F(1,34.4) = 4.26, p = 0.047], for both WBB 
and placebo, as BMI increased, performance decreased 
WBB [beta =  – 0.367, placebo beta =  – 0.244]; Word Rec-
ognition trend [F(1,33.2) = 3.63, p = 0.065].
The covariate, Age, predicted performance or inter-
acted with Beverage on the following measures: Delayed 
Recall, Age x Beverage interaction [F(1,32.4) = 7.496, 
p = 0.010], for WBB as age increased performance increased 
[beta = 0.051], conversely for placebo as age increased per-
formance decreased [beta =  – 0.020]; Word Recognition 
[F(1,30.7) = 3.22, p = 0.083].
The covariate AUC 0-120 Insulin predicted perfor-
mance on the following measures: Proactive Interfer-
ence [F(1,70.2) = 7.27, p = 0.009]; Delayed Recall 
[F(1,66.1) = 5.03, p  = 0.028]; Word Recognition 
[F(1,57.2) = 2.92, p = 0.093]. AUC 0-120 Insulin did not inter-
act with Beverage on any measure.
Fig. 8  Insulin response over the 
480 min following WBB and 
placebo treatment
Fig. 9  Triglyceride response 
over the 480 min following 
WBB and placebo treatment
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The covariate, AUC 0-120 glucose, predicted performance 
on Proactive Interference [F(1,69.3) = 5.88, p = 0.018] only 
and did not interact with Beverage on any measure.
Modified attention network task
Including the covariates Age, BMI, and AUC 0-120 of Glu-
cose and Insulin in the models did not influence the pattern 
of significance for the executive function MANT measures. 
Furthermore, BMI and AUC 0-120 Glucose did not signifi-
cantly contribute to the models.
The Age covariate predicted performance for accuracy, 
trend [F(1,35.3) = 3.19, p = 0.083] and RT [F(1,34.8) = 9.05, 
p = 0.005]. For RT there was also an Age x Beverage inter-
action [F(1,250.8) = 8.68, p = 0.004], for both WBB and 
placebo, as Age increased RT slowed [WBB beta = 4.05, 
placebo beta = 3.09]. Finally, for RT, there was a AUC 0-120 
Insulin × Beverage interaction trend [F(1,261) = 3.667, p = 0 
0.057] for WBB as AUC 0-120 Insulin increased RT became 
faster [beta =  – 0.067], conversely for placebo as AUC 0-120 
Insulin increased RT slowed [beta = 0.018].
Go/No‑Go
For the Go/No-Go RT analysis, when including the covari-
ates age, BMI, and AUC 0-120 of Glucose and Insulin the 
main effect of cue type remained a significant predictor 
of RT [F(1,102.6) = 15.8, p < 0.001]. Importantly, Bever-
age was found to marginally predict RT [F(1,105.7) = 3.82, 
p = 0.053], RT was faster after the WBB Beverage com-
pared to placebo (M = 333 ms vs M = 338 ms, respectively). 
There was also a significant Beverage × Time interaction 
[F(4,139.9) = 2.44, p < 0.05] with pairwise comparisons 
revealing the same pattern of results as seen previously. 
The AUC 0-120 Glucose and BMI covariates did not signifi-
cantly contribute to the model. The Age covariate predicted 
RT [F(1,35.7) = 13.48, p = 0.001]. Furthermore there was 
an Age x Beverage trend [F(1,108.5) = 3.32, p = 0.071], for 
both WBB and placebo as Age increased RT also slowed 
[WBB beta = 2.80, placebo beta = 2.33]. The AUC 0-120 Insu-
lin covariate predicted RT [F(1,140.3) = 9.96, p = 0.002], but 
did not interact with Beverage.
Including the covariates age, BMI, and AUC 0-120 of 
Glucose and Insulin in the model did not influence the pat-
tern of significance for the Go/No-Go error measures. The 
AUC 0-120 Glucose and age covariates did not significantly 
contribute to the model. The covariate AUC 0-120 Insulin pre-
dicted number of errors [F(1,44.6) = 4.24, p = 0.045], but did 
not interact with Beverage. There was a BMI x Beverage inter-
action trend [F(1,108.5) = 2.89, p = 0.092] whereby for WBB 
as BMI increased there was a small increase in number of 
errors [beta = 0.002] and for placebo, as BMI increased there 
was a small decrease in number of errors [beta <  – 0.001].
Discussion
This study considered for the first time the relationship 
between cognitive behaviour and metabolic responses fol-
lowing a single polyphenol-rich WBB drink with a meal in 
middle-aged adults. Similar to previous research with other 
age groups, WBB cognitive performance was improved in 
comparison to placebo on delayed recognition memory and 
aspects of executive function [16–21]. Importantly, these 
benefits were found on more demanding elements of the 
tasks where some form of additional cognitive effort was 
required. For the AVLT, rejecting foil words in the word rec-
ognition component of the AVLT would require the partici-
pant to overcome interference from the previously presented 
Fig. 10  Zero to 120 min area under the curve comparisons for a Glu-
cose and b Insulin
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list B items and 20 novel foils as opposed to recognising the 
list A items which had received repeated encoding over a 
number of trials. For the Go/No-Go task, inhibiting No-Go 
responses following a misleading ‘Go’ cue, and responding 
faster following a misleading No-Go cue requires additional 
cognitive effort to overcome the pre-potent effect of these 
cues which is not present where a facilitating congruent 
cue is given. Furthermore, it is interesting that particular 
differences were found between treatments at 120 min for 
the ‘Go’ cue errors, coinciding with previous reports of 
elevated WBB metabolites in the blood [25] and increased 
flow mediated vasodilation [40]. Differences were also found 
at 480 min again for ‘Go’ cue errors and also for invalid 
‘NoGo’ cue RT, the final test session of the day, presumably 
the point at which the participants had reduced cognitively 
resources. Although it should be noted that further differ-
ences were found at 240 min for the Word Rejection meas-
ure, and general Go/No-Go RT, indicating some evidence of 
WBB benefit in the absence of cognitive fatigue. Taken as 
a whole, these cognitive findings are in line with previous 
WBB research in children [19] and indicate that consum-
ing a whole fruit WBB drink with a meal, compared to an 
energy-matched non-WBB drink, enhanced performance on 
higher demand cognitive tasks in middle-aged participants.
Whilst flavonoid-rich blueberry interventions have dem-
onstrated improvements in measures of memory and execu-
tive function following chronic intervention [6, 10–12], Bell 
et al. [4] have noted that different cognitive domains appear 
affected following acute flavonoid/polyphenol interven-
tions dependent on the age of the participants tested with 
memory improvements generally being observed in children 
and older adults, executive function improvements in chil-
dren, younger, and middle-aged adults, and working memory 
improvements more typically observed in younger and mid-
dle-aged adults. Findings from recent acute flavonoid-rich 
berry interventions have been broadly consistent with this 
observation. For young adults, improved executive function 
performance has been demonstrated following acute grape 
juice [41], and mixed berry [21] intervention, and improved 
working memory has been shown following a grape/blue-
berry extract [42]. Conversely, for older adults, improved 
episodic memory word recognition and word recall has been 
found following haskap berry [43] and a recent blueberry 
intervention study found improvements on a global meas-
ure of cognitive performance which, when the individual 
tasks were considered separately, revealed improved word 
recognition and also a trend for improved performance on an 
EF switching task [22]. In the current study, improvements 
were found in both episodic memory and executive func-
tion performance. Although the memory effect involving the 
rejection of interfering words during the word recognition 
task might also be considered a consequence of executive 
control, it is interesting to note that the memory benefits 
found here are in line with the recent studies described above 
which also showed berry-related benefits on word recog-
nition measures. The executive function benefits were pri-
marily observed in the response inhibition Go/No-Go task, 
with little evidence being shown for a treatment effect on 
the MANT. Interestingly, in an fMRI study, Blasi et al. [44] 
found greater pre-frontal cortex activation during response 
inhibition tasks in comparison to response interference 
tasks, which showed greater nucleus accumbens (ACC) acti-
vation. Research by Dodd [45] has indicated that blueberry 
intervention increases cerebral blood flow to pre-frontal 
areas but not the ACC. It is therefore plausible that there is 
a selective increase in blood flow to brain areas mediating 
response inhibition performance on the Go/No-Go task but 
not response interference performance as was observed in 
this study.
Metabolic responses to treatments were different during 
the first 120 min post-meal (i.e., AUC 0-120) with significantly 
lower glucose and insulin recorded for WBB in comparison 
to placebo. The addition of these variables to the model as 
covariates, along with BMI and Age, had varying impact 
depending on the cognitive variable investigated. The main 
effect of treatment for word rejection was no longer signifi-
cant; however, the covariates did not significantly contrib-
ute to the model or interact with treatment. Furthermore, 
the interaction trend and significant pairwise comparisons 
remained consistent for the word rejection measure.
For the Go/No-Go task, however, the addition of the four 
covariates to the model introduced a marginal trend effect for 
faster RT performance for the Go/No-Go task in conjunction 
with WBB beverage consumption. Though both AUC 0-120 
insulin and age contributed significantly to the model for Go/
No-Go RT, only Age interacted with Beverage as a trend and 
it therefore seems probable that age is the factor most likely 
to be contributing to this RT effect. As noted above, cog-
nitive abilities, especially memory and executive abilities, 
decline with age and the interaction here between Age and 
Beverage provides further evidence for the efficacy of WBB 
treatment in ameliorating age-related cognitive decline. For 
a number of other measures, age either predicted perfor-
mance or interacted with treatment, but did not significantly 
change the previously observed pattern of results.
BMI predicted performance and interacted with treatment 
on several AVLT measures and also interacted as a trend 
with treatment on the Go/No-Go errors measure. As might 
be expected from previous research [46], the relationship 
between BMI and cognitive performance was uniformly 
negative; the only exception being the weak Go/No-Go 
interaction trend. Where the covariate analysis revealed a 
significant change in the main effect of treatment on Word 
Rejection and Go/No-Go RT, BMI did not contribute signifi-
cantly to the model. Therefore, from the results of this par-
ticular study, it might be concluded that whilst the significant 
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interactions give some evidence of a relationship between 
BMI and treatment, this is not sufficiently strong to impact 
the effect of treatment in this middle-aged sample.
It is interesting to note that AUC 0-120 Glucose only con-
tributed significantly to the model for proactive interfer-
ence and did not interact significantly with treatment on 
any measure. However, AUC 0-120 insulin contributed sig-
nificantly to three AVLT variables and the Go/No-Go Errors 
and RT measures, and interacted with treatment (as a non-
significant trend only) for MANT RT. Whilst this demon-
strates an apparently stronger relationship between insulin 
and cognitive function than between glucose and cognition, 
this would seem to be primarily independent from treatment 
in the middle-aged sample considered here.
Our metabolic findings are consistent with recent younger 
adult findings, which have shown postprandial glucose con-
centrations to be attenuated following a similar 517 mg 
anthocyanin dose to the estimated 475 mg dose used in 
the current study [47, 48]. Furthermore, in the same study, 
improved cognitive function was demonstrated on the 
demanding serial 7 s task at one and two hours following 
intervention (cognitive testing did not take place beyond two 
hours) [47]. Whilst, this converging evidence provides strong 
support for both cognitive and metabolic benefits follow-
ing WBB intervention, the lack of a statistically significant 
interaction between treatment-related changes in glucose or 
insulin concentrations and cognitive performance indicates 
that the underlying mechanisms may be more complex than 
blood glucose control alone. Another consideration would 
be that this study did not possess adequate statistical power 
to detect these associations, especially in the context of a 
strong effect for Age. Our overall power was approximately 
70%, which is a general limitation for this study. However, 
it is sufficient to provide insights supporting further consid-
eration of the way in which metabolic and cognitive factors 
interact with other physiological responses. For example, 
the three-way interaction between glucose availability and or 
insulin sensitivity, increased blood flow, and cognitive per-
formance may prove a fruitful avenue for further research.
The research had many strengths and limitations. Though 
previous research has considered younger adults, this is the 
first research to examine WBB effects relative to metabolic 
responses in a middle-age population acutely. While other 
studies examine effects of treatments in a well-rested state, 
typically after chronic intervention, our paradigm tested 
acute effects in a relatively fresh-to-fatigued model over 
the course of a day. The model also induced a metabolic 
challenge by providing subjects with a typical Western style 
meal to drink with treatment beverages. Limitations included 
a small sample size, although thirty-five subjects is larger 
than most berry trials and the cross-over design increased 
power as subjects served as their own controls. Assess-
ment of WBB metabolites would have allowed for an extra 
variable to consider in the model, as individual variability 
in flavonoid metabolism has been documented, which may 
have helped explain results.
Conclusion
Here we have presented the effects of a polyphenol-rich, wild 
blueberry intervention on acute cognitive function and meta-
bolic outcomes in middle-aged adults. The findings provide 
further support for the efficacy of wild blueberry on improv-
ing cognitive outcomes within this age group, particularly 
where there is increased cognitive demand. Wild blueberry 
was also found to reduce glucose and insulin concentrations 
in response to a meal over the initial 120 min having impli-
cations for post-meal metabolic control. Although there was 
little evidence of a direct relationship on cognition, these 
data have importance for structuring meal plans to reduce 
the metabolic burden in individuals with glucose homeo-
stasis concerns.
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